Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001796831-22-000001
Filing Date
2022-11-30
Accepted
2022-11-30 15:59:22
Documents
1
Effectiveness Date
2022-11-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7246
  Complete submission text file 0001796831-22-000001.txt   8337
Mailing Address 650 EAST KENDALL STREET BIOLABS 2ND FLOOR CAMBRIDGE MA 02142
Business Address 650 EAST KENDALL STREET BIOLABS 2ND FLOOR CAMBRIDGE MA 02142 (781) 491-9005
Ingenia Therapeutics Inc. (Filer) CIK: 0001796831 (see all company filings)

EIN.: 831818828 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-466183 | Film No.: 221435546